Black Seed Oil, Bentonite Clay, and Probiotics: A Comprehensive Holistic Cure for Clostridium difficile Infection in

Emily Littman1,2, Nicole Winningham3, Tana B Carson1,4

  • 1Occupational Therapy, University of Florida, Gainesville, FL 32611, USA.

Insights

Antibiotic resistance is rising, leading to secondary infections like Clostridium difficile (C. difficile). Naturopathic treatments, including black seed oil and probiotics, show promise for pediatric C. difficile infection (CDI) with fewer side effects.

Area of Science:

  • Pediatric infectious diseases
  • Complementary and alternative medicine (CAM)
  • Microbiome research

Background:

  • Overuse of antibiotics contributes to rising antibiotic resistance and secondary infections such as Clostridium difficile (C. difficile).
  • Conventional antibiotic treatments for C. difficile infection (CDI) can disrupt intestinal flora, leading to adverse effects, particularly in pediatric patients.
  • Naturopathic and CAM therapies offer potential alternatives with fewer side effects and reduced risk of secondary infections.

Observation:

  • A healthy two-year-old patient developed C. difficile infection (CDI) following hospitalization and antibiotic treatment for a gluteal abscess.
  • The patient's CDI was confirmed via stool immunoassay.
  • The patient had previously been treated with clindamycin, vancomycin, and piperacillin/tazobactam.

Findings:

  • A treatment plan combining black seed oil (Nigella sativa), bentonite clay, and Lactobacillus probiotics was implemented for the pediatric CDI case.
  • Following 4 days of combined CAM therapy, C. difficile was undetectable by stool immunoassay.
  • This suggests a rapid and effective resolution of CDI with the chosen naturopathic interventions.

Implications:

  • Naturopathic and CAM therapies, including black seed oil, bentonite clay, and probiotics, may serve as effective alternatives for treating pediatric C. difficile infection (CDI).
  • These findings highlight the need for further research into the efficacy and safety of CAMs as adjunct or alternative treatments for CDI in children.
  • Shared decision-making between providers and parents can lead to integrated treatment plans incorporating CAMs for pediatric infections.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
433
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
317
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
353
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
545
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
38
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
323